Development of Oncolytic viruses as potential cancer therapeutics
gem0104
CSN Member Posts: 1
I came across a very informative site that you all might be interested in. Please allow me to share it with you. It's the official website for Oncolytics Biotech, Inc. Oncolytics Biotech is a company focused on developing new treatments for cancer patients.
Oncolytics Biotech proprietary reovirus formulation, Reolysin, is active against approximately two thirds of all human cancers. The respiratory enteric orphan virus or reovirus, is a harmless virus that has shown powerful anti-cancer activity against cultured tumour cell. Check-out their site : http://www.oncolyticsbiotech.com/
Oncolytics Biotech proprietary reovirus formulation, Reolysin, is active against approximately two thirds of all human cancers. The respiratory enteric orphan virus or reovirus, is a harmless virus that has shown powerful anti-cancer activity against cultured tumour cell. Check-out their site : http://www.oncolyticsbiotech.com/
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 455 Bladder Cancer
- 311 Bone Cancers
- 1.6K Brain Cancer
- 28.6K Breast Cancer
- 407 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 802 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards